175 related articles for article (PubMed ID: 3549179)
1. In vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620 compared to that of other antimicrobial agents.
Hirschhorn L; Neu HC
Chemotherapy; 1987; 33(1):28-39. PubMed ID: 3549179
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial activity of amifloxacin (WIN 49, 375), a new quinolone agent.
Neu HC; Labthavikul P
Diagn Microbiol Infect Dis; 1985 Nov; 3(6):469-78. PubMed ID: 4064609
[TBL] [Abstract][Full Text] [Related]
3. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
McCarter YS; Mazens-Sullivan MF; Bartlett RC
Chemotherapy; 1992; 38(5):308-18. PubMed ID: 1337507
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones.
Chin NX; Novelli A; Neu HC
Antimicrob Agents Chemother; 1988 May; 32(5):656-62. PubMed ID: 3164987
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
Arpi M; Gahrn-Hansen B; Søgaard P; Bentzon MW
Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent.
Chin NX; Figueredo VM; Novelli A; Neu HC
Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):58-63. PubMed ID: 3132380
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of Ro 23-9424, a dual-action cephalosporin, compared with activities of other antibiotics.
Gu JW; Neu HC
Antimicrob Agents Chemother; 1990 Feb; 34(2):189-95. PubMed ID: 2327765
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of T-3761, a new fluoroquinolone.
Muratani T; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1992 Oct; 36(10):2293-303. PubMed ID: 1332594
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Stamm JM; Hanson CW; Chu DT; Bailer R; Vojtko C; Fernandes PB
Antimicrob Agents Chemother; 1986 Feb; 29(2):193-200. PubMed ID: 3087274
[TBL] [Abstract][Full Text] [Related]
10. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
Ismaeel NA; Tayeb OS
Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
[TBL] [Abstract][Full Text] [Related]
11. In vitro antimicrobial activity of fluoroquinolones against clinical isolates obtained in 1989 and 1990.
Chen YC; Chang SC; Hsu LY; Hsieh WC; Luh KT
J Formos Med Assoc; 1993 Dec; 92(12):1040-8. PubMed ID: 7911351
[TBL] [Abstract][Full Text] [Related]
12. [In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin].
Soussy CJ; Deforges L; Le Van Thoi J; Duval J
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):759-67. PubMed ID: 3309811
[TBL] [Abstract][Full Text] [Related]
13. In-vitro activity of newer quinolones against aerobic bacteria.
Auckenthaler R; Michéa-Hamzehpour M; Pechère JC
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing the in vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620.
Hirschhorn L; Neu HC
Antimicrob Agents Chemother; 1986 Jul; 30(1):143-6. PubMed ID: 3752975
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620.
Eliopoulos GM; Moellering AE; Reiszner E; Moellering RC
Antimicrob Agents Chemother; 1985 Oct; 28(4):514-20. PubMed ID: 3935046
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of A-56619 (difloxacin) and A-56620, two aryl fluoroquinolones.
Digranes A; Dibb WL
Chemotherapy; 1988; 34(4):298-307. PubMed ID: 3208547
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of A-56619 and A56620, two new aryl-fluoroquinolone antimicrobial agents.
Smith BR; LeFrock JL; Donato JB; Joseph WS; Weber SJ
Antimicrob Agents Chemother; 1986 Feb; 29(2):355-8. PubMed ID: 3717937
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of PD 117596-2, a broad-spectrum difluoroquinolone.
Neu HC; Chin NX
Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):644-50. PubMed ID: 2506029
[TBL] [Abstract][Full Text] [Related]
19. CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteria.
Fuchs PC; Barry AL; Jones RN; Thornsberry C; Ayers LW; Gavan TL; Gerlach EH
Diagn Microbiol Infect Dis; 1987 Mar; 6(3):185-92. PubMed ID: 3471371
[TBL] [Abstract][Full Text] [Related]
20. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
Bassey CM; Baltch AL; Smith RP
J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]